cbdMD (YCBD) EPS (Weighted Average and Diluted) (2017 - 2025)
cbdMD (YCBD) has disclosed EPS (Weighted Average and Diluted) for 9 consecutive years, with -$0.17 as the latest value for Q3 2025.
- Quarterly EPS (Weighted Average and Diluted) rose 92.11% to -$0.17 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$0.17 through Sep 2025, up 92.11% year-over-year, with the annual reading at -$1.09 for FY2025, 92.39% up from the prior year.
- EPS (Weighted Average and Diluted) hit -$0.17 in Q3 2025 for cbdMD, up from -$2.14 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.02 in Q2 2021 to a low of -$11.77 in Q3 2022.
- Historically, EPS (Weighted Average and Diluted) has averaged -$1.88 across 5 years, with a median of -$0.35 in 2021.
- Biggest five-year swings in EPS (Weighted Average and Diluted): surged 109.4% in 2021 and later crashed 16717.39% in 2022.
- Year by year, EPS (Weighted Average and Diluted) stood at -$0.35 in 2021, then surged by 76.54% to -$0.08 in 2022, then plummeted by 10061.44% to -$8.34 in 2023, then surged by 74.32% to -$2.14 in 2024, then skyrocketed by 92.11% to -$0.17 in 2025.
- Business Quant data shows EPS (Weighted Average and Diluted) for YCBD at -$0.17 in Q3 2025, -$2.14 in Q3 2024, and -$0.15 in Q2 2024.